These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12136371)

  • 1. Pharmacokinetics of doxepin and desmethyldoxepin: an evaluation with the population approach.
    Meyer-Barner M; Meineke I; Schreeb KH; Gleiter CH
    Eur J Clin Pharmacol; 2002 Jul; 58(4):253-7. PubMed ID: 12136371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective pharmacokinetics of doxepin isomers.
    Midha KK; Hubbard JW; McKay G; Hawes EM; Korchinski ED; Gurnsey T; Cooper JK; Schwede R
    Eur J Clin Pharmacol; 1992; 42(5):539-44. PubMed ID: 1607001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxicologic findings in suicide with doxepin and paroxetine].
    Musshoff F; Grellner W; Madea B
    Arch Kriminol; 1999; 204(1-2):28-32. PubMed ID: 10489589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability investigation of two different oral formulations of doxepin.
    Geister U; Gaupp M; Arnold P; Schaarschmidt D; Doser K; Renner J
    Arzneimittelforschung; 2001; 51(3):189-96. PubMed ID: 11304934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxepin concentrations in plasma and cerebrospinal fluid.
    Schomburg R; Remane D; Fassbender K; Maurer HH; Spiegel J
    J Neural Transm (Vienna); 2011 Apr; 118(4):641-5. PubMed ID: 21350940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of E- and Z-doxepin and E- and Z-desmethyldoxepin by high-performance liquid chromatography.
    Adamczyk M; Fishpaugh JR; Harrington C
    Ther Drug Monit; 1995 Aug; 17(4):371-6. PubMed ID: 7482692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic determination of trans-doxepin and desmethyldoxepin.
    Dilger C; Salama Z; Jaeger H
    Arzneimittelforschung; 1988 Oct; 38(10):1525-8. PubMed ID: 3196396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute bioavailability and stereoselective pharmacokinetics of doxepin.
    Yan JH; Hubbard JW; McKay G; Korchinski ED; Midha KK
    Xenobiotica; 2002 Jul; 32(7):615-23. PubMed ID: 12162857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage schedule and plasma levels of doxepin and desmethyldoxepin.
    Biggs JT; Preskorn SH; Ziegler VE; Rosen SH; Meyer DA
    J Clin Psychiatry; 1978 Oct; 39(10):740-2. PubMed ID: 711683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of doxepin by Cunninghamella elegans.
    Moody JD; Freeman JP; Cerniglia CE
    Drug Metab Dispos; 1999 Oct; 27(10):1157-64. PubMed ID: 10497142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective in vivo and in vitro studies on the metabolism of doxepin and N-desmethyldoxepin.
    Yan JH; Hubbard JW; McKay G; Midha KK
    Xenobiotica; 1997 Dec; 27(12):1245-57. PubMed ID: 9460230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal doxepin intoxication--suicide or slow gradual intoxication?
    Neukamm MA; Vogt S; Hermanns-Clausen M; Naue J; Thierauf A; Auwärter V
    Forensic Sci Int; 2013 Apr; 227(1-3):82-4. PubMed ID: 22999230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective and simultaneous measurement of cis- and trans-isomers of doxepin and N-desmethyldoxepin in plasma or urine by high-performance liquid chromatography.
    Yan J; Hubbard JW; McKay G; Midha KK
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):131-8. PubMed ID: 9140766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of plasma metabolites during human PET-studies with three receptor ligands, [11C]YM-09151-2, [11C]doxepin and [11C]pyrilamine.
    Ishiwata K; Yanai K; Iwata R; Takahashi T; Hatazawa J; Itoh M; Watabe K; Watanabe T; Ido T
    Tohoku J Exp Med; 1996 Feb; 178(2):129-36. PubMed ID: 8727694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic evaluation of two doxepin products.
    Wecker MT; Woodworth JR; Amsel LP; Hinsvark ON; Rotenberg KS
    Clin Ther; 1986; 8(3):342-7. PubMed ID: 3719617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assays for doxepin and desmethyldoxepin using high-performance liquid chromatography and high-performance thin-layer chromatography.
    Faulkner RD; Lee C
    J Pharm Sci; 1983 Oct; 72(10):1165-7. PubMed ID: 6644564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay for doxepin and desmethyldoxepin.
    Virtanen R; Salonen JS; Scheinin M; Iisalo E; Mattila V
    Acta Pharmacol Toxicol (Copenh); 1980 Oct; 47(4):274-8. PubMed ID: 7468227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
    Rao ML; Deister A; Laux G; Staberock U; Höflich G; Möller HJ
    Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic factors affecting antidepressant drug clearance and clinical effect: evaluation of doxepin and imipramine--new data and review.
    Ereshefsky L; Tran-Johnson T; Davis CM; LeRoy A
    Clin Chem; 1988 May; 34(5):863-80. PubMed ID: 3286056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.